These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin. Bates SM; Weitz JI Br J Pharmacol; 2005 Apr; 144(8):1017-28. PubMed ID: 15711585 [TBL] [Abstract][Full Text] [Related]
3. New anticoagulants. Linkins LA; Weitz JI Semin Thromb Hemost; 2003 Dec; 29(6):619-31. PubMed ID: 14719178 [TBL] [Abstract][Full Text] [Related]
4. Emerging anticoagulants: mechanism of action and future potential. Klement P; Rak J Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459 [TBL] [Abstract][Full Text] [Related]
5. The status of new anticoagulants. Bates SM; Weitz JI Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562 [TBL] [Abstract][Full Text] [Related]
6. New antithrombotic agents. Castelli R; Porro F; Savo D; Cassinerio E Panminerva Med; 2006 Dec; 48(4):247-56. PubMed ID: 17215797 [TBL] [Abstract][Full Text] [Related]
7. Emerging anticoagulants for the treatment of venous thromboembolism. Weitz JI Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267 [TBL] [Abstract][Full Text] [Related]
8. Review of the rebound phenomenon in new anticoagulant treatments. Hermans C; Claeys D Curr Med Res Opin; 2006 Mar; 22(3):471-81. PubMed ID: 16574031 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of plasmatic coagulation: what is new?]. Schwarz M; Bode C Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059 [TBL] [Abstract][Full Text] [Related]
10. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials of new anticoagulants. Anderson J; O'Donnell M Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460 [TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change. Zikria JC; Ansell J Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318 [TBL] [Abstract][Full Text] [Related]
13. Ximelagatran: a new oral anticoagulant. Hrebickova L; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322 [TBL] [Abstract][Full Text] [Related]
14. Antitumor and antimetastatic effect of warfarin and heparins. Bobek V; KovarÃk J Biomed Pharmacother; 2004 May; 58(4):213-9. PubMed ID: 15183845 [TBL] [Abstract][Full Text] [Related]
15. New strategies for the treatment of acute venous thromboembolism. Prandoni P; Lensing AW; Pesavento R Semin Thromb Hemost; 2006 Nov; 32(8):787-92. PubMed ID: 17171591 [TBL] [Abstract][Full Text] [Related]
16. New anticoagulants for venous thromboembolic disease. Chang P IDrugs; 2004 Jan; 7(1):50-7. PubMed ID: 14730467 [TBL] [Abstract][Full Text] [Related]